Interphase Clinical Trials: Phase III/Phase IV

DOI<link itemprop=identifier href="https://doi.org/10.1002/(SICI)1521-4036(199911)41:7<773::AID-BIMJ773>3.0.CO;2-8" /><773::AID-BIMJ773>3.0.CO;2-8 10.1002/(SICI)1521-4036(199911)41:7<773::AID-BIMJ773>3.0.CO;2-8zbMath0947.62074OpenAlexW2004720503MaRDI QIDQ4937306

Patrick Blin, John O'Quigley, Yves Charpak, Ronghui Xu

Publication date: 12 November 2000

Full work available at URL: https://doi.org/10.1002/(sici)1521-4036(199911)41:7<773::aid-bimj773>3.0.co;2-8

zbMATH Keywords

predictionsurvival analysisextrapolationclinical trialsregression errorsproportional hazard regressionphase III studiesphase IV studies

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Linear inference, regression (62J99) Survival analysis and censored data (62N99)

This page was built for publication: Interphase Clinical Trials: Phase III/Phase IV